Tax title and license fees in illinois

eBay

2008.01.25 18:46 eBay

The unofficial eBay subreddit. Help for buyers and sellers. Please read the rules - https://old.reddit.com/Ebay/about/rules/
[link]


2013.03.25 13:10 noagendamarket This subreddit is for users of Bitcoin in Australia.

This subreddit is for users of Bitcoin in Australia.
[link]


2013.10.14 02:21 Syncdata Car advice for people who know jack about cars

Car model advice and general buying discussion.
[link]


2024.05.15 15:04 Finding_Way_ Taxes: do you have them taken out of social security disbursements?

As stated in the title, what do you all do, if you are collecting social security, about taxes? Do you have a certain percentage taken out of your social security before receiving it monthly or pay quarterly taxes or pay at tax time?
Same with your pensions, if applicable, how do you handle taxes? In looking ahead at our social security statements and pension statements I'm trying to estimate what our take home would be if we have taxes taken out...or how we would pay if we pay another way.
Both social security and pension seem to have the option of having taxes taken out before disbursements, but not required.
This question may sound a bit ignorant, but we are still in the planning stages and I would appreciate input from this always wise group!
submitted by Finding_Way_ to retirement [link] [comments]


2024.05.15 14:59 Constant-Staff9800 TOP Trending everywhere! 200k MC - 90k Liquidity - 48h old - Utility IS LIVE! - Online Retail & Payment gateway - GreenWAVES - GRWV

Introducing a hugely undervalued gem, GreenWAVES ($GRWV) – Your Gateway to the Future of E-commerce! Powered by the Binance Smart Chain , GreenWAVES revolutionizes online retail with its cutting-edge web3 shop and ecommerce payment gateway by allowing users to setup their shop for free and start selling right away! With GreenWAVES, anyone can effortlessly create their own online store and kickstart their entrepreneurial journey with a generous $125 free budget for selling. Say goodbye to upfront costs – all shops are free to set up! And with a nominal fee of just $1 upon reaching $125 in sales, you can keep the momentum going with ease. Enjoy the benefits of zero taxes and a user-friendly interface, making selling a breeze. As a low marketcap gem, GreenWAVES is KYC'd, audited, and launched just one month ago with zero fees. Join the movement and embrace the future of online retail with GreenWAVES today!
Website: https://greenwav.es App: https://grwv.app
Contract Address: 0x8DE4228d54FC86D4607c8425e8bECEfB93888fe4 Marketcap: 200.000 Chain: Binance Smart Chain - BEP20 Launched: 48 hours ago Token Type: Utility Security: Owner KYC'd, Token audited with a perfect audit score of 0 issues Contract Renounced: YES Listings: Bitgert, CoinGecko DONE, CoinMarketCap Soon Marketing: Press Release and News sites (including Digital Journal, MarketWatch, Bloomberg, Benzinga, Yahoo News, Yahoo Finance, Google News) , Twitter Shillings & AMA's, Reddit Shilling, Telegram Shilling, Call Channels, AMA's. Token build: 0% Fees, Contract renounced Goals: Populating the alerady existing GreenWAVES dAPP, Tier 1-2 CEX listings, Utility wide spread, mainstream media pick up, short term plans are to be as much known as possible & Top 100 Crypto by Marketcap
Learn more about GreenWAVES and join the ecosystem. 100x done, another 100x to come.
Twitter: https://x.com/greenwav_es
submitted by Constant-Staff9800 to CryptoMoonShots [link] [comments]


2024.05.15 14:59 SaulGoode9 Advice Needed on AM4 vs AM5 Build Comparison

Build Help/Ready:

Have you read the sidebar and rules? (Please do)
Yes.
What is your intended use for this build? The more details the better.
Gaming at 1440p -Would like to play games such as Baldur's Gate 3 and Witcher 3 on high-ultra settings at 1440p.
General and work purposes - nothing major, but use of some online collaboration tools/board which can be memory intensive (16GB more than sufficient for this).
Future upgrades - I would like to upgrade in 2-4 years, so I am heavily considering an AM5 build to save me from having to start again from scratch due to phasing out of AM4 in that timeframe.
If gaming, what kind of performance are you looking for? (Screen resolution, framerate, game settings)
1440p on high to ultra setting on titles including Baldur's Gate 3, Witcher 3, Civilization series. Frame rate of 65-80fps minimum.
** What is your budget (ballpark is okay)?**
Approx €900-1100 (~US$1000-1200)
In what country are you purchasing your parts?
Belgium, though willing to look at other European stores depending on price.
Post a draft of your potential build here (specific parts please). Consider formatting your parts list. Don't ask to be spoonfed a build (read the rules!).
I have put together 2 possible builds. The first is an AM4 build on the lower end of the budget (€908), which I think should be able to meet my requirements. The second is an AM5 build which stretches the budget (€1163). Both have a RX 6750 XT (6800 XT doesn't seem to be available from any retailers in Belgium).
I intend on upgrading in 2-3 years, which is my motivation for going AM5. However, I am hesitating on this as I am not sure whether the future-prep is worth the extra money, especially given it'll be the same GPU as the cheaper build until then. AM5 build is already at the hard limit budget-wise, as I will also need a monitor.
If anyone has any feedback or suggestions for better optimising these builds, and any thoughts on whether going AM5 is worth it for a relative budget build, that would be fantastic.
BUILD 1 PCP and PartPicker Part List
Type Item Price
CPU AMD Ryzen 5 5600X 3.7 GHz 6-Core Processor €131.90 @ Amazon Belgium
Motherboard MSI MPG B550 GAMING PLUS ATX AM4 Motherboard €119.00 @ Amazon Belgium
Memory G.Skill Ripjaws V 16 GB (2 x 8 GB) DDR4-3200 CL16 Memory €51.16 @ Azerty
Storage Crucial P3 1 TB M.2-2280 PCIe 3.0 X4 NVME Solid State Drive €76.16 @ Azerty
Video Card XFX Speedster QICK 319 Core Radeon RX 6750 XT 12 GB Video Card €352.00 @ Amazon Belgium
Case Phanteks Eclipse G300A (1 Fan) ATX Mid Tower Case €65.89 @ Alternate Belgium
Power Supply SHARKOON SilentStorm Cool Zero 750 750 W 80+ Gold Certified Fully Modular ATX Power Supply €109.90 @ Amazon Belgium
Prices include shipping, taxes, rebates, and discounts
Total €906.01
Generated by PCPartPicker 2024-05-15 14:39 CEST+0200
BUILD 2 PCPartPicker Part List
Type Item Price
CPU AMD Ryzen 5 7600X 4.7 GHz 6-Core Processor €209.90 @ Amazon Belgium
CPU Cooler ARCTIC Alpine 23 CPU Cooler €11.76 @ Azerty
Motherboard MSI B650 GAMING PLUS WIFI ATX AM5 Motherboard €164.95 @ Megekko
Memory Kingston FURY Beast 16 GB (2 x 8 GB) DDR5-5600 CL36 Memory €69.90 @ Amazon Belgium
Storage Crucial P3 Plus 1 TB M.2-2280 PCIe 4.0 X4 NVME Solid State Drive €81.31 @ Azerty
Video Card XFX Speedster QICK 319 Core Radeon RX 6750 XT 12 GB Video Card €352.00 @ Amazon Belgium
Case Phanteks Eclipse G300A (1 Fan) ATX Mid Tower Case €65.89 @ Alternate Belgium
Power Supply Corsair RM750e (2023) 750 W 80+ Gold Certified Fully Modular ATX Power Supply €107.80 @ Amazon Belgium
Prices include shipping, taxes, rebates, and discounts
Total €1063.51
Generated by PCPartPicker 2024-05-15 14:52 CEST+0200
Provide any additional details you wish below.
Wifi adaptor is a must. Bluetooth would also be nice.
submitted by SaulGoode9 to buildapc [link] [comments]


2024.05.15 14:55 Phev_Vin Mazda cx90 PHEV Preferred 10k mile update

9.5 months since purchase.
10k miles. 72 MPG based on the car's calculations ( which doesnt account for electricity price).
Put premium gas only from Costco. Average since purchase: $3.6 per gallon. To compare, regular gas average is $3.1.
Price of "super off peak" electricity including taxes and a whole lot of fees Georgia Power shoves on me: $0.045 / Kwh.
Always start on EV mode and deplete battery.
Get 25.6 miles in gas only mode ( after full battery depletion). Mostly 50/50 city/hwy driving. Kept EV miles vs gas miles notes diligently between a tank fill and did the math.
Averaged 1.91 Miles/Kwh on EV. The Mazda calculation is off, and shows much higher, because it largely counts regen braking miles as EV miles ( even when the battery is depleted). I compare against EV miles driven divided by my Kwh draw in the night. Summer time, its closer to 2.4 ( with no AC). However, during last winter it dropped to 1.4 Mi/Kwh.
So true Miles per gallon ( including electricity cost, and premium gas extra cost) using the average gas prices above:
72 × 3.1 / (3.6 + (72-25.6)×.045/1.91)
= 47.56 Miles per gallon.
Usually carry 4 people but in winter carried 8 people for a few weeks.
Also, 2.5 more months in summer for a full year and it will only go up: unless we take a road trip which will bring it down a lot.
However road trips should be excluded as it is the second cheapest ( after EV road trip but dont want to burn an hour for every 3 driven) , and most convenient option for us for trips < 1500 miles.
I like driving the car. It feels hard on the butt sometimes during longer drives. And the front bushing creaking still shows on dry days. No issues otherwise.
submitted by Phev_Vin to MazdaCX90 [link] [comments]


2024.05.15 14:42 LeonAdelmanMD EM Workforce Newsletter: 48 States & The Feds Don't Require a Doctor in the ER

EM Workforce Newsletter: 48 States & The Feds Don't Require a Doctor in the ER
An emergency department should have a physician on-site. Seems obvious, right?
According to a Virginia College of Emergency Physicians poll, “97% of respondents in Virginia believe that patients presenting to an emergency department deserve physician-led care.”
However, 48 states do not require a physician to be present in licensed emergency departments. Many of those states defer to the federal Critical Access Hospital regulations, which stipulate that EDs must staff “a doctor of medicine or osteopathy, a physician assistant, a nurse practitioner, or a clinical nurse specialist, with training or experience in emergency care.”
To read the rest of the post, head to: https://open.substack.com/pub/emworkforce/p/48-states-and-the-feds-dont-require
https://preview.redd.it/7a6h78aa5l0d1.png?width=1272&format=png&auto=webp&s=7c2857d2d04ecccaf29865690cf583f883a68e6c
submitted by LeonAdelmanMD to emergencymedicine [link] [comments]


2024.05.15 14:41 louied91 Dyadic Announces First Quarter 2024 Financial Results and Highlights Recent Company Progress

News Link: https://www.globenewswire.com/news-release/2024/05/14/2881828/0/en/Dyadic-Announces-First-Quarter-2024-Financial-Results-and-Highlights-Recent-Company-Progress.html
Human Health Sector
Animal Health Sector
Alternative Proteins Sector
Corporate
JUPITER, Fla., May 14, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a biotechnology company focused on the efficient large-scale manufacture of proteins for use in human and animal vaccines and therapeutics, as well as non-pharmaceutical applications including food, nutrition, and wellness, today announced its financial results for the first quarter of 2024 and highlighted recent Company progress.
“We continue to execute our business strategy to focus on near-term pharmaceutical and non-pharmaceutical applications for our proprietary and patented C1 and Dapibus™ protein production platforms and pipeline products,” said Mr. Mark Emalfarb, President and CEO of Dyadic. “One of our key highlights was the successful completion of a Phase 1 clinical trial that met its primary endpoint of safety and reactogenicity affirming the safety of proteins produced by Dyadic's C1 platform in humans. We believe this milestone not only establishes the safety of our platform but also provides a solid foundation for C1 technology’s future applications in human and animal vaccines and therapeutics. With the H5N1 ('Bird Flu') virus outbreaks in poultry and U.S. dairy cows, along with one recent human case, we are seeing an increasing interest in our H5N1 'Bird Flu' ferritin nanoparticle human vaccine candidate, developed with ViroVax. Additional animal studies indicate that the vaccine candidate has the potential to generate high neutralizing antibodies for use in cattle. Our Q1 2024 achievements demonstrate our ongoing commitment to enhancing our microbial platforms for diverse applications, and our dedication to improving health for humans and animals, while tackling the challenges of sustainable food production.”
Mr. Emalfarb continued, “As we progress into the second quarter, our Company continues to focus on enhancing the Dapibus™ platform, designed specifically for non- pharmaceutical uses in industries such as food, nutrition, health, and other bioproducts. To accomplish this goal, we have honed our business development strategy, focusing on key areas where our technologies can deliver the greatest impact with shorter commercialization timelines. Our strategy includes simultaneously targeting multiple offtakes for a single product in several corresponding business segments and seeking out new opportunities that are in line with our strategy.”
Joe Hazelton, Dyadic’s Chief Operating Officer, elaborated, “In addition to operational advancements, we also strengthened our financial position with the issuance of $6.0 million in convertible notes, which will be used to accelerate and exploit our strategic objective of near-term revenue generating products and commercialization opportunities for pharmaceutical and non-pharmaceutical applications. We believe that product opportunities such as recombinant human albumin and alpha-lactalbumin provide Dyadic with multiple monetization opportunities as a licensed product or cell line in pharmaceutical, diagnostic, and food applications. We are confident that our strong position, both financially and scientifically, will enable us to implement our business plans with improved capabilities and resources. We are enthusiastic about our future prospects and remain committed to providing value to our customers and stakeholders.”
Recent Company Progress
Corporate Events:
~Human Health Sector~
DYAI-100 Phase 1 Clinical Trial
DYAI-100, a C1-SARS-CoV-2 recombinant protein RBD vaccine candidate, is the first C1-expressed protein tested in humans. The Phase 1 randomized, double-blind, placebo-controlled trial was designed as a first-in-human trial to assess the clinical safety and antibody response of DYAI-100, produced using the C1 platform and administered as a booster vaccine at two single dose levels in healthy volunteers. Following regulatory clearance from the South African Health Products Regulatory Authority (SAHPRA), the trial was initiated in 1Q 2023, with the last patient visit occurring in 3Q 2023. On November 29, 2023, the Company announced the top-line safety results, indicating that the study has met its primary endpoint that both the low and high dose levels of the vaccine are safe and well tolerated among participants. Additionally, the vaccine has been shown to induce immune responses at both dose levels, suggesting its potential efficacy in generating protective immunity against the target virus. The study has been finalized, and the final Clinical Study Report has been issued, demonstrating that the DYAI-100 vaccine met its primary endpoint of safety and reactogenicity.
~Animal Health Sector~
~Alternative Proteins Sector~
Dyadic is advancing a pipeline of differentiated product candidates that leverage its microbial protein production platforms, including Dapibus™ which have demonstrated the ability and efficiency to enable the rapid development and large-scale manufacture of proteins at low cost in a wide range of non-pharmaceutical applications and commercial use.
Cell Culture Media Products
Non-animal Dairy Products
Bio Industrial Products
Financial Highlights
Cash Position: As of March 31, 2024, cash, cash equivalents, and the carrying value of investment-grade securities, including accrued interest, were approximately $12.1 million compared to $7.3 million as of December 31, 2023.
Revenue: Research and development revenue and license revenue for the three months ended March 31, 2024, decreased to approximately $335,000 compared to $934,000 for the same period a year ago. The decrease in research and development revenue was due to the winding down of several large research collaborations conducted in 2023. For the three months ended March 31, 2024, the Company’s revenue was generated from ten collaborations compared to seven collaborations in the same period a year ago.
Cost of Revenue: Cost of research and development revenue for the three months ended March 31, 2024, decreased to approximately $144,000 compared to $727,000 for the same period a year ago. The decrease in cost of research and development revenue was due to the same reasons as for revenue described above.
R&D Expenses: Research and development expenses for the three months ended March 31, 2024, decreased by 35.5% to approximately $523,000 compared to $811,000 for the same period a year ago. The decrease reflected the winding down of activities related to the Company’s Phase 1 clinical trial of DYAI-100 COVID-19 vaccine candidate and a decrease in the amount of ongoing internal research projects.
G&A Expenses: General and administrative expenses for the three months ended March 31, 2024, increased by 20.9% to approximately $1,789,000 compared to $1,480,000 for the same period a year ago. The increase reflected increases in business development and investor relations expenses of approximately $138,000, audit fees of $99,000, management incentives of $59,000, and other increases of $59,000, offset by decreases in insurance expenses of $29,000 and legal expenses of $17,000.
Loss from Operations: Loss from operations for the three months ended March 31, 2024, slightly increased to $2,126,000, compared to $2,050,000 for the same period a year ago.
Net Loss: Net loss for the three months ended March 31, 2024, was $2,010,000 or $(0.07) per share compared to $956,000 or $(0.03) per share for the same period a year ago. The increase in net loss was derived from the sale of the Company’s equity interest in Alphazyme LLC for $989,000 in 2023.
Conference Call Information: Date: Tuesday, May 14, 2024 Time: 5:00 p.m. Eastern Time Dial-in numbers: Toll Free 877-407-0784 International +1-201-689-8560 Conference ID: 13743568 Webcast link: https://viavid.webcasts.com/starthere.jsp?ei=1650831&tp_key=0f89478e24
An archive of the webcast will be available within 24 hours after completion of the live event and will be accessible on the Investor Relations section of the Company’s website at www.dyadic.com. To access the replay of the webcast, please follow the webcast link above.
submitted by louied91 to nasdaq [link] [comments]


2024.05.15 14:23 Relevant-Math-4155 Is Edward Jones worth it?

I have an IRA with Edward Jones (my father left it for me when she passed). Edward Jones did nothing to grow the money, and I've been hacked to bit by taxes and fees. There will soon be only $20,000 left in the IRA, and I'm wondering if I could do better someplace else.
Edward jones has never offered any strategies to soften the tax hits, and their fees have really hurt. Could I do better with another firm?
Also, is there any way to grow the money? My Edward Jones advisor has said there is no way to grow my money and I should just use it while I have it.
I'll appreciate any ideas.
submitted by Relevant-Math-4155 to investing [link] [comments]


2024.05.15 14:20 HotSarcasm $ADAP: Adaptimmune Reports Q1 2024 Financial and Business Updates

$ADAP: Adaptimmune Reports Q1 2024 Financial and Business Updates
  • Afami-cel commercial and regulatory update presented at Company's Investor Day; FDA review and inspections progressing with PDUFA date of August 4th, 2024
  • Commercial and manufacturing infrastructure in place to support afami-cel commercial launch upon approval
  • Data from SPEARHEAD-1 pivotal trial with afami-cel published in ~The Lancet~; data from a planned interim analysis of pivotal lete-cel IGNYTE-ESO trial to be presented at ASCO
  • Cash runway into late 2025
Philadelphia, Pennsylvania and Oxford, United Kindgom--(Newsfile Corp. - May 15, 2024) - Adaptimmune Therapeutics plc (NASDAQ: ADAP), a company redefining the treatment of solid tumor cancers with cell therapy, today reports financial results and business updates for the first quarter ended March 31, 2024. The Company will host a live webcast at 8:00 a.m. EDT (1:00 p.m. BST) today.
Adrian Rawcliffe, Adaptimmune's Chief Executive Officer: "Support from the sarcoma community continues to highlight the high unmet medical need for new therapies for synovial sarcoma and we are making great progress preparing for the commercial launch of afami-cel on approval. Behind afami-cel, we plan to launch lete-cel for synovial sarcoma and MRCLS in 2026 with projected peak US sales of $400 million for our sarcoma franchise."
Sarcoma Franchise with afami-cel and lete-cel
  • U.S. FDA accepted the BLA for afami-cel for the treatment of advanced synovial sarcoma with priority review and a PDUFA date of August 4th, 2024
  • The BLA mid-cycle review meeting was held with FDA in April
  • FDA GCP Bioresearch Monitoring Program (BIMO) inspections have been conducted at Adaptimmune and at selected clinical sites that participated in the pivotal SPEARHEAD-1 trial
  • FDA GMP Pre-license inspections (PLI) have taken place at the Company's Navy Yard facility and at the lentiviral vector contract manufacturer's facility
  • Preliminary plans for confirmatory evidence for afami-cel's full approval were previously agreed with FDA, including Cohort 2
  • Adaptimmune expects to discuss post-marketing requirements and commitments at the late-cycle meeting which is scheduled for the second half of May
  • To date, the FDA has not requested an Advisory Committee meeting or a REMS program
  • The marketing application for the companion diagnostic for MAGE-A4 is currently under FDA review and is expected to be approved contemporaneously with the BLA
  • Adaptimmune is preparing to launch afami-cel on approval in the U.S. Initially, launch will be focused on 6-10 selected treatment centers ("Authorized Treatment Centers" or "ATCs") and will expand to up to ~30 ATCs.
  • 100% of the customer facing commercial and medical affairs teams is now in place
  • Company launched www.Tcrtcell.com: an unbranded website aimed at educating healthcare providers about TCR T-cell therapy in solid tumors, including synovial sarcoma, and the role of biomarkers and testing to determine future treatments
  • The second product in Adaptimmune's sarcoma franchise, lete-cel, is being investigated in the pivotal IGNYTE-ESO trial (NCT03967223), which at a planned interim analysis exhibited response in 18/45 of patients (ORR 40%). The primary efficacy endpoint requires 16/60 patients have responses, so this trial has met its primary endpoint for efficacy. The full pivotal analyses are anticipated in late 2024.
  • Lete-cel will enable Adaptimmune to expand its addressable synovial sarcoma patient population by targeting the NY-ESO cancer antigen, in addition to MAGE-A4 targeted by afami-cel, as well as treating Myxoid Round Cell Liposarcoma (MRCLS) patients.
  • Sarcoma franchise of afami-cel and lete-cel leverages same development and commercial footprint with US peak year sales projected to be up to $400 million
  • Data presentations
    • Data from pivotal SPEARHEAD-1 trial with afami-cel published in The Lancet: article entitled "Afamitresgene autoleucel for advanced synovial sarcoma and myxoid round cell liposarcoma (SPEARHEAD-1): an international, open-label, phase 2 trial"
    • Data from the planned interim analysis of the pivotal IGNYTE-ESO trial with lete-cel to be presented by Dr. Sandra P. D'Angelo, M.D., Sarcoma Medical Oncology, Memorial Sloan Kettering Cancer Center, in an oral presentation at ASCO entitled "Lete-cel in patients with synovial sarcoma or myxoid/round cell liposarcoma: Planned interim analysis of the pivotal IGNYTE-ESO trial" during the Developmental Therapeutics-Immunotherapy session in Hall D2 on June 3, 2024 at 11:30 a.m. CDT
Clinical pipeline
  • Uzatresgene autoleucel ("uza-cel", formerly ADP-A2M4CD8) is being investigated in the SURPASS-3 Phase 2 clinical trial (NCT05601752) for the treatment of platinum-resistant ovarian cancer. Uza-cel received FDA RMAT designation in 2022 for the treatment of patients with platinum resistant ovarian cancer. The SURPASS-3 trial is currently enrolling patients.
  • Cohorts in the Phase 1 SURPASS trial are ongoing for people with head & neck and urothelial (bladder) cancers with uza-cel in combination with standard of care checkpoint inhibitor therapy.
Preclinical pipeline
  • IND-enabling studies are underway for ADP-600 (PRAME) and ADP-520 (CD70) programs.
  • Wholly owned allogeneic pipeline advancing; process development in progress at Adaptimmune's allogeneic manufacturing facility in Milton Park, UK.
  • Data presentation
    • Poster presented by George Pope, Ph.D., Associate Director Preclinical Safety at Adaptimmune, entitled "Development and Preclinical Characterization of an Engineered T-Cell Therapy Targeting PRAME-Expressing Solid Tumors" at the American Society of Gene & Cell Therapy (ASGCT) Annual meeting
Corporate news
  • As announced earlier today, Adaptimmune has secured up to $125 million in debt financing with Hercules Capital with the first tranche of $25 million available upon closing; and an additional $25 million available upon afami-cel approval
  • Cash runway into late 2025 which includes current cash on hand, anticipated revenues from the launch of afami-cel, expected future income from partners and other non-dilutive capital sources including the Company's new debt facility with Hercules Capital
  • Company announced that its strategic collaboration with Genentech was terminated
~Financial Results for the three months ended March 31, 2024~
  • Cash / liquidity position: As of March 31, 2024, Adaptimmune had cash and cash equivalents of $140.7 million and Total Liquidity\1]) of $143.7 million, compared to $144.0 million and $146.9 million respectively, as of December 31, 2023.
  • Revenue: Revenue for the three months ended March 31, 2024, was $5.7 million compared to $47.6 million for the same period in 2023. Revenue has decreased in 2024, compared to the same period in 2023 primarily due to the termination of the Astellas collaboration in the first quarter of 2023, resulting in the remaining deferred income for the collaboration being recognized as revenue in March 2023.
  • Research and development (R&D) expenses: R&D expenses for the three months ended March 31, 2024, were $35.2 million compared to $25.5 million for the same period in 2023. R&D expenses in the three months ended March 31, 2024 increased in employee-related costs and additional costs associated with lease properties following the acquisition of TCR2in June 2023 and a decrease in offsetting reimbursements receivable for research and development tax and expenditure credits.
  • General and administrative (G&A) expenses: G&A expenses for the three months ended March 31, 2024, were $19.7 million compared to $20.4 million for the same period in 2023. G&A expenses in the three months ended March 31, 2024 decreased due to restructuring and charges recognised in the first quarter of 2023 and a decrease in other corporate costs due to an increase in accounting, legal and professional fees incurred in relation to the TCR2Therapeutics, Inc merger agreement that were not repeated in 2024, offset by an increase in depreciation due to leasehold improvements capitalised in 2023.
  • Net loss/profit: Net loss attributable to holders of the Company's ordinary shares for the three months March 31, 2024, was $48.5 million ($(0.03) per ordinary share), compared to a profit of $1.0 million ($0.00 per ordinary share), for the same periods in 2023.
Financial Guidance The Company believes that its existing cash, cash equivalents and marketable securities, together with anticipated revenues from the launch of afami-cel, expected future income from partners and other non-dilutive capital sources including the Company's new debt facility with Hercules Capital announced earlier today, will fund the Company's current operations into late 2025, as further detailed in the Company's Quarterly Report on Form 10-Q for the three months ended March 31, 2024, to be filed with the Securities and Exchange Commission following this earnings release.
Today's Webcast Details A live webcast and replay can be accessed at https://www.gowebcasting.com/13334**.** Call in information is as follows: 1-800-806-5484 (US or Canada) or +416-340-2217 (International and additional options available HERE) and the passcode is 3025919#. Callers should dial in 5-10 minutes prior to the scheduled start time and simply ask to join the Adaptimmune call.
About Adaptimmune Adaptimmune is a clinical-stage biopharmaceutical company focused on designing, developing, and delivering cell therapies to transform the lives of people with cancer. The Company's unique engineered T-cell receptor (TCR) platform enables the engineering of T-cells to target and destroy cancers across multiple solid tumor types.
Forward-Looking Statements This release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 (PSLRA). These forward-looking statements involve certain risks and uncertainties. Such risks and uncertainties could cause our actual results to differ materially from those indicated by such forward-looking statements, and include, without limitation: the success, cost and timing of our product development activities and clinical trials and our ability to successfully advance our TCR therapeutic candidates through the regulatory and commercialization processes. For a further description of the risks and uncertainties that could cause our actual results to differ materially from those expressed in these forward-looking statements, as well as risks relating to our business in general, we refer you to our Annual Report on Form 10-K filed with the Securities and Exchange Commission for the year ended 31 December, 2023, our Quarterly Reports on Form 10-Q, Current Reports on Form 8-K, and other filings with the Securities and Exchange Commission. The forward-looking statements contained in this press release speak only as of the date the statements were made and we do not undertake any obligation to update such forward-looking statements to reflect subsequent events or circumstances.
Total Liquidity (a non-GAAP financial measure) Total Liquidity (a non-GAAP financial measure) is the total of cash and cash equivalents and marketable securities (available-for-sale debt securities). Each of these components appears separately in the condensed consolidated balance sheet. The U.S. GAAP financial measure most directly comparable to Total Liquidity is cash and cash equivalents as reported in the condensed consolidated financial statements, which reconciles to Total Liquidity as follows (in thousands):
https://preview.redd.it/hsnd589f1l0d1.png?width=1318&format=png&auto=webp&s=5c2d7bc5f2f06871993309dc9b4e125672e82dfd
The Company believes that the presentation of Total Liquidity provides useful information to investors because management reviews Total Liquidity as part of its assessment of overall solvency and liquidity, financial flexibility, capital position and leverage.
Condensed Consolidated Statement of Operations (unaudited, in thousands, except per share data)
https://preview.redd.it/6lyfu3gj1l0d1.png?width=1642&format=png&auto=webp&s=7e8d43f0c148dac5f17389d0e6891fbcbe634052
Condensed Consolidated Balance Sheets (unaudited, in thousands, except share data)
https://preview.redd.it/1ro5ubbp1l0d1.png?width=1474&format=png&auto=webp&s=148a070d003d85bcbbc258d996e3f85b586bcb65
Condensed Consolidated Cash Flow Statement (unaudited, in thousands)
https://preview.redd.it/mdyx2ups1l0d1.png?width=1368&format=png&auto=webp&s=fcbea401b0e4a5add6c2f6c41be868a29151fd22
FULL RELEASE: https://www.adaptimmune.com/investors-and-media/news-centepress-releases/detail/268/adaptimmune-reports-q1-2024-financial-and-business-updates
submitted by HotSarcasm to adaptimmune [link] [comments]


2024.05.15 14:09 samrraimi YouTube/Adsense tax

do I need any license/certificate or anything to get paid by adsense? I have a youtube channel that makes me 2-3k$ a month, and I'm currently getting paid in Turkey. I want to switch my adsense account to UAE to get paid here, but I don't know if I need anything to legally get paid and pay taxes in UAE. I'm currently on a work visa and I have a bank account.
submitted by samrraimi to UAETeenagers [link] [comments]


2024.05.15 14:08 samrraimi YouTube/Adsense tax

do I need any license/certificate or anything to get paid by adsense? I have a youtube channel that makes me 2-3k$ a month, and I'm currently getting paid in Turkey. I want to switch my adsense account to UAE to get paid here, but I don't know if I need anything to legally get paid and pay taxes in UAE. I'm currently on a work visa and I have a bank account.
submitted by samrraimi to uaelaw [link] [comments]


2024.05.15 14:08 samrraimi YouTube/Adsense tax

do I need any license/certificate or anything to get paid by adsense? I have a youtube channel that makes me 2-3k$ a month, and I'm currently getting paid in Turkey. I want to switch my adsense account to UAE to get paid here, but I don't know if I need anything to legally get paid and pay taxes in UAE. I'm currently on a work visa and I have a bank account.
submitted by samrraimi to UAE [link] [comments]


2024.05.15 14:07 samrraimi YouTube/Adsense tax

do I need any license/certificate or anything to get paid by adsense? I have a youtube channel that makes me 2-3k$ a month, and I'm currently getting paid in Turkey. I want to switch my adsense account to UAE to get paid here, but I don't know if I need anything to legally get paid and pay taxes in UAE. I'm currently on a work visa and I have a bank account.
submitted by samrraimi to dubai [link] [comments]


2024.05.15 14:03 MilkFanClub Can I get my money back after traffic tickets related expenses

Some context, I was blocked in by police at a parking lot. The officer wouldn’t tell me what they stopped me for and requests my license. They then instructed me to follow them as they were doing “vehicle inspections” they wouldn’t return my license or tell me where I was going just to follow them. I did so and they were hosting a vehicle inspections point with 20 plus officers in a commercial parking lot. After a good 3 hours They ended up charging me with “improper muffler” and “drive motor vehicle not within emissions regulations”. The officer issuing the tickets did not tell me why I was getting them only what my legal options are. I had to find an officer to tell me what was going on. The only reason they could say was I didn’t have a “primary cat” and that it was “unsafe” , they insisted I had an exhaust leak but wouldn’t tell me where. they removed my plates and called a tow truck. They refused to let me use CAA as they already took my plates.
I had it towed to my mechanic which was able to disprove the lack of “primary cat” and that the vehicle was safe to drive. They insisted the vehicle was modified and made false claims saying it was lowered which the vehicle was stock and only serviced by a reputable mechanic.
I had to pay for my own tow and now pay for safety, registration and new plates.
I intend to fight the tickets but is there a way to get reimbursed for the tow and the fees with getting the vehicle on the road if I were to win?
submitted by MilkFanClub to legaladvicecanada [link] [comments]


2024.05.15 14:01 jbaird Reducing China's greenhouse emissions

Emissions per country
Given that China is far away the largest greenhouse gas emitter and also still rapidly building coal plants what can we do in the west to actually deal with this problem?
Yes I know they are also making large strides in solaetc.. that is some hope but also seems like total emissions are still rising which is a problem
Also USA since they're #2 but I think that topic has been done a thousand times
Also India, Russia, Brazil..
I was going to title this something like 'how we we counter the argument that China emissions make everything else not matter" as that does get brought up all the time in Canada at least given our fairly low overall emissions (and very high per capita emissions!) but it should be about solving actual problems not winning stupid internet arguments, less emissions is better and unfortunately China is a big problem
I believe the EU is going to bring in some carbon tax on imports which would be my first thought for Canada/etc to adopt too although I guess China's manufacturing is only 11% of their emissions which seems low
but what else could work? are there other solutions?
submitted by jbaird to climatechange [link] [comments]


2024.05.15 13:54 ElizaDoo Please help me find the Music Album “Jump In” (2005) from Sylvia Tosun. Some songs were used in Dawson’s Creek

Hello everyone! :D
I was watching Dawson's Creek streaming on Amazon Prime. It is well-known between fans of the show that the streaming platform and DVD versions have their own music, which is different from the one of the original broadcast. This is because the original music licenses didn't include DVD or other types of distribution. Many of these WB shows have very obscure songs on their DVD/streaming versions that not even Shazam recognizes and are difficult to track.
Anyway, on the end of Episode 1 of Season 5 titled "The Bostonians" there is this song called "Once and Always You" by Sylvia Tosun. It belongs to the album Jump In, from the same singer and published in 2005. I wasn't able to find neither the song or the album on streaming platforms (Spotify, Apple Music/Itunes), YouTube (I only found the songs "We belong" and "Head Over Heels", nothing else), SoundCloud (info about the album can be found, but nothing else), Archive (info about the album with 30 seconds mp3 samples of each track can be found here) and even Soulseek. But I came up with nothing.
I even tried reaching out to Sylvia Tosun on Facebook, but it seems she does not use her Social Media pages since 2020. I also contacted Miklos Malek, the producer of the album and I am yet to receive an answer.
The only place you can find the album is physically on Amazon, but it costs $144 USD and it does not ship to my country. I though about contacting the person who left the only review on the Amazon page, but I am not sure if I found the right person or not.
I ended up ripping the part of the song that's used on the DC chapter, which you can find here, but the quality is horrible and it has dialogue over the song.
Any help you can give me finding this album or song in a higher quality would be greatly appreciated :D I published it on at first, but they told me to search here. Thank you!
(PS: I censored the cover of the album with a Sylvanian Doll because I want to respect the NSFW guidelines, but you can see the proper cover in the links I have attached).
submitted by ElizaDoo to HelpMeFind [link] [comments]


2024.05.15 13:53 SleepyheadZ10 Agents of a telco want 20% of the contract price

Supposed Agents of a telco offered to lease 300 sq.m of our lot for 5M. The initial offer was 5M for 30 years but later on they said we will only be receiving 4M because the remainder will go to the 16 agents who processed/will be processing this transaction. They are asking for a copy of our title, tax declaration, spa etc. to be submitted with the telco for approval. I am quite hesitant to proceed with the transaction because 1M as commission is too much and that they could easily buy our land with this amount, why lease?
If you are in my position, would you proceed with this transaction? If yes, what precautionary measures will you take?
submitted by SleepyheadZ10 to LawPH [link] [comments]


2024.05.15 13:53 According-Wonder6928 Target Practice Spammer Fake Maps

It anyone wants target practive or does not believe fake maps are real here is a example. The spammer owns all 4 maps and knows that proximity address maps has a better chance to rank.
Also Pure Lead Gen, No business license, Keywords in Title, Sells fake tickets to these address on eventbrite tells customers it got cancelled but I can do this... for you. This is the Golden Age for Spammers no punishment
Example 1 - Spammers has a strip club at the bank
Example 2 - Spammer moved the address to another address inside a Resturant called Fig
Example 3 - This one is impossible to take down via redressal or suggest. Burned down abandon building
Example 4 - A apartment complex location
submitted by According-Wonder6928 to GoogleMyBusiness [link] [comments]


2024.05.15 13:51 More_Soft_6801 Inquiry Regarding Tax Deduction of Master's Tuition Fees

Hello Members,
I am Non EU citizen and relocated from Switzerland to Germany in May 2023. I am classified in Tax Class 5, while my husband is in Tax Class 3. My master's studies at a Swiss university commenced in February 2022, and I am set to complete the course in September 2024. Since May 2023, I occasionally travel to the Swiss University for semester exams, attending most lectures online.
For the tax year 2023, I am filing jointly with my husband. Will the master's tuition fees that we paid in February 2023 and September 2023 be considered tax-exempt income in Germany?
Thank you.
submitted by More_Soft_6801 to germany [link] [comments]


2024.05.15 13:47 Total-Mastodon-6888 The Essential Guide to the Immigration Process: Your Roadmap to a New Beginning

The prospect of immigrating to a new country can be both exciting and daunting. It represents a chance to chase dreams, explore new horizons, and build a fulfilling life. However, the immigration process itself can seem like a labyrinth of complex procedures and unfamiliar terminology. Here at Adric Immigration Consultants
in Bangalore, we’re dedicated to empowering you with knowledge and guidance throughout this journey.
This comprehensive guide serves as your roadmap to navigating the essential steps of the immigration process, providing clarity and demystifying the path ahead.
Step 1: Identifying Your Goals and Visa Options
The first step is to clearly define your aspirations. Are you seeking temporary work opportunities, pursuing higher education, or aiming for permanent residency? Understanding your goals will steer you towards the most suitable visa category.
Common Immigration Objectives and Corresponding Visas:
Researching Visa Options:
Each visa category has specific eligibility requirements, application procedures, and processing timelines. Utilize the official government websites of your target country for the most up-to-date information. Here are some helpful resources:
Consulting an Immigration Consultant:
Immigration laws are intricate and constantly evolving. Partnering with a reputable immigration consultant like Adric Immigration Consultants can significantly benefit your journey. Our experienced professionals can:
Step 2: Preparing the Necessary Documentation
Once you’ve identified the relevant visa category, meticulous document preparation becomes crucial. Common documents required for most visa applications include:
Meeting Specific Requirements:
Each visa category might have additional documentation requirements. It’s crucial to meticulously review the specific guidelines for your chosen visa to ensure you submit all necessary documents.
Obtaining Certified Documents:
Certain documents might require translation by a certified translator and official legalization or apostille seals from the issuing authority. Plan accordingly to avoid delays in the application process.
Step 3: Completing the Application Process
Visa applications typically involve online forms and submission of supporting documentation. Here’s a general breakdown of the process:
Step 4: Awaiting the Decision and Potential Next Steps
Processing times for visa applications can vary significantly depending on the visa category, workload of the processing center, and individual circumstances. Once you submit your application, you will receive a tracking number or case ID to monitor the status online.
Approval: If your application is approved, you will receive your visa electronically or affixed to your passport. Carefully review the validity period and any conditions associated with your visa.
Denial: If your application is denied, a notification will be issued explaining the reason for denial. In such cases, consulting with your immigration consultant is crucial. Depending on the reason for denial, you might be able to reapply after addressing the issues or explore alternative visa options.
Administrative Processing: Sometimes, applications require additional administrative processing, which can extend the waiting period. Stay patient and maintain open communication with your immigration consultant during this time.
Step 5: Entering the New Country and Maintaining Status
Once you receive your visa and make travel arrangements, ensure you have all necessary documents readily available for border crossing. Upon arrival, a border officer will verify your documents and grant entry for the authorized period.
Maintaining Visa Status: For temporary visas, it’s crucial to comply with the conditions and duration of your stay. Overstaying your visa can have serious consequences, including deportation and ineligibility for future visas.
Transitioning to Permanent Residency: For those pursuing permanent residency, the process often involves additional steps after initial entry, such as obtaining a green card (U.S.) or permanent resident card (Canada). Adric Immigration Consultants can guide you through these subsequent procedures.
Partnering with Adric Immigration Consultants for a Smoother Journey
The immigration process can be intricate, and navigating it alone can be stressful. At Adric Immigration Consultants in Bangalore, we understand the complexities involved and provide you with the expert guidance and support you need throughout your journey.
Our Services:
Contact us today for a free consultation and let our experienced immigration consultants transform your immigration dream into a reality. With Adric Immigration Consultants by your side, you can embark on this exciting new chapter with clarity, confidence, and peace of mind.
submitted by Total-Mastodon-6888 to u/Total-Mastodon-6888 [link] [comments]


2024.05.15 13:42 Responsible-Map-5465 Best love marriage specialist Astrologer

Best love marriage specialist Astrologer Astrologer Mukesh Pandit Ji indeed stands out as one of the best love marriage specialists in the field of astrology. With his profound knowledge of Vedic astrology and years of experience, he has helped countless individuals navigate the complexities of love and marriage. Here’s why Astrologer Mukesh Pandit Ji is considered the best love marriage specialist:
Expertise in Vedic Astrology: Astrologer Mukesh Pandit Ji has a deep understanding of Vedic astrology, an ancient Indian science that offers profound insights into human life and relationships. He utilizes this knowledge to analyze birth charts, planetary positions, and astrological influences to provide accurate predictions and effective remedies. Specialization in Love Marriages: Unlike many general astrologers, Astrologer Mukesh Pandit Ji specializes specifically in love marriages. He understands the unique challenges faced by couples in love unions, such as parental opposition, cultural differences, and compatibility issues, and offers tailored solutions to address them. Compassionate Guidance: Astrologer Mukesh Pandit Ji approaches his clients with empathy and compassion. He listens attentively to their concerns, respects their individual circumstances, and provides guidance with the utmost care and understanding. Effective Remedies: One of the hallmarks of Astrologer Mukesh Pandit Ji’s practice is the effectiveness of his remedies. Whether it’s recommending specific gemstones, performing puja rituals, or prescribing mantra chanting, his remedies have helped countless couples overcome obstacles and strengthen their bond. Proven Track Record: Over the years, Astrologer Mukesh Pandit Ji has built a solid reputation for his accurate predictions and successful outcomes. Many satisfied clients have attested to the positive changes they’ve experienced in their love marriages after seeking guidance from him. Accessibility: Astrologer Mukesh Pandit Ji ensures that his services are accessible to individuals from all walks of life. Whether you’re located in India or abroad, he offers consultations through various channels, including phone calls, video calls, and email, making it convenient for clients to seek his guidance. Ethical Practices: Integrity and ethics are paramount in Astrologer Mukesh Pandit Ji’s practice. He maintains the highest standards of professionalism and confidentiality, ensuring that clients feel comfortable sharing their concerns and trust his guidance wholeheartedly. For these reasons and more, Astrologer Mukesh Pandit Ji is widely regarded as one of the best love marriage specialists in the field of astrology. His dedication to helping couples find happiness and harmony in their relationships has earned him the respect and admiration of clients worldwide.
Certainly! Here’s some additional information about Astrologer Mukesh Pandit Ji and his expertise as a love marriage specialist:
Personalized Approach: Astrologer Mukesh Pandit Ji believes in providing personalized solutions tailored to the specific needs of each client. He takes the time to understand the unique dynamics of every relationship and offers guidance accordingly, ensuring that his recommendations resonate with the individual circumstances of the couple. Holistic Perspective: In addition to his astrological expertise, Astrologer Mukesh Pandit Ji adopts a holistic approach to love marriages. He considers various factors, including psychological, emotional, and spiritual aspects, to provide comprehensive guidance that addresses the root causes of any issues in the relationship. Continued Support: Astrologer Mukesh Pandit Ji doesn’t just offer temporary solutions; he provides continued support to his clients throughout their journey. Whether it’s through follow-up consultations, regular check-ins, or ongoing guidance, he remains dedicated to helping couples overcome challenges and nurture their love for the long term. Educational Initiatives: Beyond his consultations, Astrologer Mukesh Pandit Ji is committed to empowering individuals with knowledge about love and relationships. He conducts workshops, seminars, and educational sessions to raise awareness about the dynamics of love marriages and equip people with tools to navigate them successfully. Respected Authority: Astrologer Mukesh Pandit Ji is not only trusted by his clients but also respected within the astrological community. His insights and contributions to the field have earned him recognition as a leading authority on love marriages, and he is often sought after for his expertise by fellow astrologers and practitioners. Cultural Sensitivity: Given the diverse cultural landscape of India, Astrologer Mukesh Pandit Ji approaches his practice with cultural sensitivity and respect for traditional values. Whether clients come from different backgrounds or follow different customs, he ensures that his guidance is inclusive and respectful of their cultural beliefs and practices. Positive Impact: The impact of Astrologer Mukesh Pandit Ji’s work extends beyond individual clients; it ripples through families and communities, fostering greater understanding, harmony, and love. His dedication to promoting healthy and fulfilling relationships has touched the lives of many, leaving a lasting legacy of positivity and transformation. Recognition and Awards: Astrologer Mukesh Pandit Ji’s contributions to the field of astrology have been recognized through various awards and accolades. His commitment to excellence and service has earned him the admiration of peers and clients alike, further solidifying his reputation as a preeminent love marriage specialist. Astrologer Mukesh Pandit Ji’s holistic approach, personalized guidance, and unwavering commitment to his clients make him a trusted ally for anyone seeking assistance with their love marriage. His profound insights, compassionate demeanor, and dedication to positive change have made a significant impact on countless lives, earning him the title of one of the foremost love marriage specialists in India.

FAQ

Certainly! Here are some frequently asked questions (FAQ) about Astrologer Mukesh Pandit Ji’s services as a Love Marriage Specialist:
Q: What is a Love Marriage Specialist, and what services do they provide? A Love Marriage Specialist is an astrologer who specializes in addressing issues related to love relationships and marriages. They provide a range of services including compatibility analysis, resolving conflicts, overcoming parental opposition, and offering astrological remedies to strengthen the bond between couples. Q: How can Astrologer Mukesh Pandit Ji help me with my love marriage issues? Astrologer Mukesh Pandit Ji offers personalized guidance and remedies to address various challenges faced by couples in love marriages. Whether it’s resolving conflicts, gaining parental approval, or enhancing compatibility, he provides effective solutions based on astrological insights. Q: Is it necessary to believe in astrology for Astrologer Mukesh Pandit Ji’s services to work? While belief in astrology is not a prerequisite, having an open mind and willingness to explore astrological insights can enhance the effectiveness of the remedies suggested by Astrologer Mukesh Pandit Ji. Q: How accurate are the predictions and remedies provided by Astrologer Mukesh Pandit Ji? Astrologer Mukesh Pandit Ji’s predictions and remedies are based on extensive knowledge of Vedic astrology and years of experience. While outcomes may vary depending on individual circumstances, many clients have reported positive results and improvements in their love marriages after following his guidance. Q: Can I consult with Astrologer Mukesh Pandit Ji if I’m located outside of India? Yes, Astrologer Mukesh Pandit Ji offers consultations to clients worldwide through various channels such as phone calls, video calls, and email. Regardless of your location, you can seek his guidance and assistance for your love marriage issues. Q: Are consultations with Astrologer Mukesh Pandit Ji confidential? Yes, consultations with Astrologer Mukesh Pandit Ji are strictly confidential. He respects the privacy of his clients and ensures that all personal information and discussions remain confidential. Q: How can I schedule a consultation with Astrologer Mukesh Pandit Ji? To schedule a consultation with Astrologer Mukesh Pandit Ji, you can contact his office via phone, email, or visit his official website. His team will assist you in booking an appointment at a convenient time. Q: What are the fees for consultations with Astrologer Mukesh Pandit Ji? The fees for consultations with Astrologer Mukesh Pandit Ji may vary depending on the nature and duration of the session. However, his services are reasonably priced, ensuring accessibility to individuals from all walks of life. These FAQs provide valuable information for individuals considering seeking assistance from Astrologer Mukesh Pandit Ji, the Love Marriage Specialist. They address common queries about his services, consultation process, confidentiality, effectiveness of remedies, and accessibility.
https://mukeshshastriji.com/best-love-marriage-specialist-astrologe
submitted by Responsible-Map-5465 to u/Responsible-Map-5465 [link] [comments]


2024.05.15 13:40 Revolutionary_Worry5 Buyer in neighboring town asking for a meetup. Advice?

So, I had listed a travel clock from WWII for $265. A friend of mine who frequents auctions has me list all of his good finds and I collect a percentage off of whatever I sell for him on eBay. I list phones and electronics mainly but I get a lot of antiques and jewelry from him to list and we’ve been doing pretty well with it.
The other day I was with him and got an offer for $239 and he said to take it, so I did. The buyer paid $259.20 in taxes and fees and we cleared $204.26 which we expected. After the transaction took place, I noticed the buyer lived into a neighboring city near mine and we chuckled at the coincidence.
She messaged me a few minutes ago offering to pick the item up, but she has already paid for shipping. Is this in violation of eBay’s policy since she paid for USPS Ground? I also saw the message at the top saying do not transfer information about selling outside of eBay. Please let me know!
submitted by Revolutionary_Worry5 to eBaySellers [link] [comments]


2024.05.15 13:37 2hunna- $2500 For Counter Strike 2

What will you be doing with this PC? Be as specific as possible, and include specific games or programs you will be using.
What is your maximum budget before rebates/shipping/taxes?
When do you plan on building/buying the PC? Note: beyond a week or two from today means any build you receive will be out of date when you want to buy.
What, exactly, do you need included in the budget? (ToweOS/monitokeyboard/mouse/etc)
Which country (and state/province) will you be purchasing the parts in? If you're in US, do you have access to a Microcenter location?
If reusing any parts (including monitor(s)/keyboard/mouse/etc), what parts will you be reusing? Brands and models are appreciated.
Will you be overclocking? If yes, are you interested in overclocking right away, or down the line? CPU and/or GPU?
Are there any specific features or items you want/need in the build? (ex: SSD, large amount of storage or a RAID setup, CUDA or OpenCL support, etc)
Do you have any specific case preferences (Size like ITX/microATX/mid-towefull-tower, styles, colors, window or not, LED lighting, etc), or a particular color theme preference for the components?
Do you need a copy of Windows included in the budget? If you do need one included, do you have a preference?
Extra info or particulars:
submitted by 2hunna- to buildapcforme [link] [comments]


http://rodzice.org/